Dr. Mohamed Yousry Elgendi, an assistant professor at Khalifa University, has been appointed to the editorial board of Communications Medicine, a Nature Portfolio journal ranked in the 95th percentile globally. His appointment reflects a broader shift in how the medical publishing world is evaluating and prioritizing artificial intelligence-driven healthcare research.

Why Does a Journal's Editorial Board Matter for AI Healthcare?

When a researcher joins an editorial board at a top-tier medical journal, they gain significant influence over which studies get published, how peer review unfolds, and ultimately what the global medical community considers credible and important. For AI healthcare specifically, this matters enormously. Dr. Elgendi's appointment signals that Communications Medicine is doubling down on publishing rigorous research in digital medicine, physiological sensing, and AI-enabled health monitoring.

As an editorial board member, Dr. Elgendi will handle manuscripts within his areas of expertise, oversee the peer-review process, support scientific quality and integrity, and help maintain high standards for research accepted for publication. He will also serve as a journal ambassador, strengthening engagement between Communications Medicine and the international research community and promoting the dissemination of high-quality clinical and translational research.

What Makes Dr. Elgendi's Credentials Stand Out?

Dr. Elgendi has authored more than 170 scientific publications and has been recognized as one of the world's top 2% of scientists in the global citation-impact database developed by Stanford University researchers since 2021. His research integrates artificial intelligence, physiological sensing, and digital biomarkers to advance cardiovascular monitoring, remote patient assessment, and precision digital health. His work has contributed to advances in photoplethysmography (a non-invasive technique that uses light to measure blood flow), wearable biosensing, remote physiological monitoring, cuffless cardiovascular assessment, and machine-learning-enabled healthcare technologies.

Before joining Khalifa University, Dr. Elgendi held research and leadership positions at several prestigious institutions, including ETH Zurich, the University of British Columbia, the University of Alberta, and Nanyang Technological University. His research has supported international collaborations across academia, healthcare, and industry, contributing to advances in digital medicine and the translation of AI-enabled physiological monitoring systems into healthcare applications.

How Is Dr. Elgendi Shaping the Next Generation of AI Healthcare Researchers?

Beyond his editorial role, Dr. Elgendi has supervised and mentored more than 60 undergraduate and postgraduate researchers. Many of these researchers have subsequently pursued opportunities at internationally recognized institutions, including MIT, Harvard University, Columbia University, the University of Pennsylvania, ETH Zurich, Carnegie Mellon University, and the University of Melbourne. This mentorship pipeline suggests that his influence on AI healthcare research extends far beyond journal gatekeeping into the training of the field's future leaders.

• Editorial Responsibilities: Handling manuscripts within areas of expertise, overseeing peer-review processes, and maintaining high standards for research quality and scientific integrity.
• Ambassador Role: Strengthening engagement between Communications Medicine and the international research community while promoting dissemination of high-quality clinical and translational research.
• Research Leadership: Mentoring more than 60 researchers who have gone on to positions at top global institutions including MIT, Harvard, and ETH Zurich.

Dr. Elgendi commented on his new role, stating: "I am honored to join the editorial board of Communications Medicine and serve as an ambassador for the journal. These roles reflect Khalifa University's growing international leadership in biomedical innovation and digital medicine. I look forward to working with the journal's editors and international research community to uphold scientific rigor, strengthen global engagement and support the translation of innovative discoveries into meaningful improvements in healthcare and patient outcomes".

Dr. Elgendi

Communications Medicine itself ranks first among 11 journals in the Assessment and Diagnosis category according to Scopus data accessed in August 2026, underscoring the journal's prominence in publishing research on how diseases are identified and evaluated. Dr. Elgendi's appointment to its editorial board strengthens Khalifa University's international visibility in AI-enabled biomedical innovation and digital medicine while supporting its commitment to research excellence and global scientific collaboration.

The appointment also reflects a broader recognition that AI-driven digital medicine is no longer a niche research area but a central pillar of modern healthcare innovation. By bringing someone with Dr. Elgendi's track record and global standing into a key editorial role, Communications Medicine is positioning itself to curate and validate the most rigorous, impactful research in this rapidly evolving field.